| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in CVKD over the last quarter tilts toward selling: insiders offloaded a net 24,499 shares worth roughly $79K.
CVKD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 98.6K | $191.3K | - | |
| Dir | 5.0K | $9.7K | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Pham Quang X49 | CEO And Chairman | Buy | 70,000 | $0.91 | $63,945.00 | +0.4% | -48.4% | -43.0% | |
| Mar 21, 2023 | Murphy John Raymond50 | Director | Buy | 10,000 | $1.39 | $13,900.00 | +1.7% | +26.4% | -52.0% | |
| Mar 16, 2023 | Murphy John Raymond50 | Director | Buy | 20,000 | $1.67 | $33,398.00 | +3.6% | +7.2% | -60.6% |